References
- Bernard R-P. Latin America and Europe first decade AIDS Atlas-GEO-2 cumulative incidence through September 1991. AIDS-Forschung 1993; 8: 127–150
- Leinikki P, Haikala O, Salminen M, Kantanen ML. HIV ja AIDS Suomessa [in Finnish]. Suomen Lääkarilehti 1994; 34: 3624–3629
- Parry JV, Mahoney A, Mortimer PP. Are seroepidemiological surveys for human immunodeficiency virus infection based on tests on pools of serum specimens accurate and cost-effective?. Clin Diagn Virol 1993; 1: 167–168
- Behets F, Bertozzi S, Kasali M, Kashamuka M, Atikala L, Brown C, Ryder RW, Quinn TC. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 1990; 4: 737–741
- Frösner GG, Dobler G, von Sonnenburg F JF. Cost reduction of unlinked testing for anti-HIV by investigation of pooled sera [short communication]. AIDS 1990; 4: 73–75
- Raboud JM, Sherlock C, Schechter MT, Lepins DG, O'Shaghnessy MV. Combining pooling and alternative algorithms in seroprevalence studies. J Clin Microbiol 1993; 31: 2298–2302
- Emmanuel JC, Bassett MT, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol 1988; 41: 582–585
- Cahoon-Yong B, Chandler A, Livermore T, Gaudino J, Benjamin R. Sensitivity and specificity of pooled versus individual sera in a Human Immunodeficiency Virus antibody prevalence study. J Clin Microbiol 1989; 27: 1893–1895
- Aho K, Kantanen ML, Cantell K, Brink A, Pönkä A. Screening for HIV antibody during pregnancy [letter]. Lancet 1987; i: 921
- Kantanen ML, Cantell K, Aho K, Brink A, Pönkä A. Screening for HIV antibody during pregnancy. Serodiag Immunol Infect Dis 1988; 2: 113–115
- WHO Global Programme on AIDS. Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. WHO Weekly Epidemiol Rec 1990; 37: 281–283, 1990
- Pönkä A, Cantell K, Kantanen ML, Leinikki P, Vartiainen E, Haikala O, Hovi S, Weckström P. Community screening for HIV infection in Finland [letter]. Am J Public Health 1989; 79: 522
- Federal Centre for AIDS Working Group on Anonymous Unlinked HIV seroprevalence Research. Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence researh. Can Med Assoc J 1992; 146: 1743–1744
- Monzon OT, Paladin F JE, Dimaandal E, Balis AM, Samson C, Mitchell S. Relevance of antibody content and test format in HIV testing of pooled sera. AIDS 1993; 6: 43–48
- Mortimer JY. Saving tests by pooling sera – how great are the benefits?. J Clin Pathol 1980; 33: 1120–1121
- Kline RL, Brothers TA, Brookmeyer R, Zeger S, Quinn TC. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol 1989; 27: 1449–1452
- AIDS Surveillance in Europe. 1993, Quarterly Report No 37. Saint-Maurice, France: European Centre for the Epidemiological Monitoring of AIDS
- Salminen M, Nykänen A, Brummer-Korvenkontio H, Kantanen ML, Liitsola K, Leinikki P. Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993; 195: 185–194
- Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. Morbid Mortal Wkly Rep 1994; 43: 285–287
- Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Inf Dis 1994; 19: 664–666